Your browser doesn't support javascript.
loading
Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification.
Okimoto, Leandro Y S; Mendonca-Neto, Rayol; Nakamura, Fabíola G; Nakamura, Eduardo F; Fenyö, David; Silva, Claudio T.
Afiliación
  • Okimoto LYS; Institute of Computing, Universidade Federal do Amazonas, Manaus, BR, Brazil. okimoto@icomp.ufam.edu.br.
  • Mendonca-Neto R; Institute of Computing, Universidade Federal do Amazonas, Manaus, BR, Brazil.
  • Nakamura FG; Institute of Computing, Universidade Federal do Amazonas, Manaus, BR, Brazil.
  • Nakamura EF; Institute of Computing, Universidade Federal do Amazonas, Manaus, BR, Brazil.
  • Fenyö D; New York Univesity, New York, USA.
  • Silva CT; New York Univesity, New York, USA.
BMC Bioinformatics ; 25(1): 92, 2024 Mar 01.
Article en En | MEDLINE | ID: mdl-38429657
ABSTRACT

BACKGROUND:

In recent years, researchers have made significant strides in understanding the heterogeneity of breast cancer and its various subtypes. However, the wealth of genomic and proteomic data available today necessitates efficient frameworks, instruments, and computational tools for meaningful analysis. Despite its success as a prognostic tool, the PAM50 gene signature's reliance on many genes presents challenges in terms of cost and complexity. Consequently, there is a need for more efficient methods to classify breast cancer subtypes using a reduced gene set accurately.

RESULTS:

This study explores the potential of achieving precise breast cancer subtype categorization using a reduced gene set derived from the PAM50 gene signature. By employing a "Few-Shot Genes Selection" method, we randomly select smaller subsets from PAM50 and evaluate their performance using metrics and a linear model, specifically the Support Vector Machine (SVM) classifier. In addition, we aim to assess whether a more compact gene set can maintain performance while simplifying the classification process. Our findings demonstrate that certain reduced gene subsets can perform comparable or superior to the full PAM50 gene signature.

CONCLUSIONS:

The identified gene subsets, with 36 genes, have the potential to contribute to the development of more cost-effective and streamlined diagnostic tools in breast cancer research and clinical settings.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: BMC Bioinformatics Asunto de la revista: INFORMATICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: BMC Bioinformatics Asunto de la revista: INFORMATICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Reino Unido